Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0.790. It has been cited 193 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.790
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cancer Prevention and Research Institute of Texas
Grant: CPRIT RP200443
Cancer Prevention and Research Institute of Texas
Grant: P30 CA08748
Cancer Prevention and Research Institute of Texas
Grant: RP180672
National Institutes of Health
Grant: R01CA269733
National Institutes of Health
Grant: DP2CA225212
National Cancer Institute
Grant: P30CA125123
U.S. Department of Defense
Grant: R21AI159379
U.S. Department of Defense
Grant: CA210522
National Center for Research Resources
Grant: S10RR024574
NCI NIH HHS
Grant: R37 CA248478
NCI NIH HHS
Grant: P30 CA008748
AstraZeneca
Lions Medical Research Foundation
Novartis Pharmaceuticals Corporation
American Association for Cancer Research
Cycle for Survival
Cancer Research Institute
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
FWCI
34.81
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals